PMID- 23980639 OWN - NLM STAT- MEDLINE DCOM- 20141031 LR - 20231213 IS - 1440-1746 (Electronic) IS - 0815-9319 (Linking) VI - 29 IP - 3 DP - 2014 Mar TI - HLA-DP and gamma-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection. PG - 533-9 LID - 10.1111/jgh.12378 [doi] AB - BACKGROUND AND AIM: Studies show that polymorphisms in human leukocyte antigen (HLA)-DP loci and certain gamma-interferon (IFN-gamma) signaling pathway genes are related to persistence of hepatitis B virus (HBV) infection and viral load in chronic HBV (CHB) infection respectively. Our study aims to determine whether single-nucleotide polymorphisms (SNPs) linked to HLA-DP loci and IFN-gamma signaling pathway are associated with HBV activities. METHODS: We compared the SNPs in the HLA-DPA1 gene (rs3077) and the IFN-gamma receptor-2 gene (rs2284553 and rs9808753) of 100 treatment-naive hepatitis B e antigen (HBeAg)-negative CHB patients with undetectable HBV DNA with 100 age- and sex-matched controls with HBV DNA > 2000 IU/mL. RESULTS: The median age of the study group was 47.9 years, and 61% were male patients. The distribution of the three polymorphisms was in Hardy-Weinberg equilibrium. Both rs3077 and rs2284553 polymorphisms were not associated with HBV viral load in terms of allelic frequency, genotypic frequency, dominant/recessive gene action. rs9808753 (G allele) was associated with a reduced chance of "undetectable HBV DNA" for patients below the age of 50 years in allelic frequency analysis (odds ratio 0.562; 95% confidence interval, 0.326-0.967; P value = 0.037). IFN-gamma receptor-2 gene haplotype block (rs2284553/rs9808753) was not associated with HBV viral activity. CONCLUSION: There was no significant association between HLA-DP polymorphism (rs3077) and IFN-gamma receptor-2 gene polymorphism (rs2284553) with viral activity in HBeAg-negative CHB patients. Further studies are required to confirm the association between IFN-gamma receptor-2 gene polymorphism (rs9808753) and reduced chance of having "undetectable HBV DNA" in young CHB patients. CI - (c) 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. FAU - Lam, Yuk-Fai AU - Lam YF AD - Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. FAU - Wong, Danny Ka-Ho AU - Wong DK FAU - Seto, Wai-Kay AU - Seto WK FAU - To, Kelvin Kai-Wang AU - To KK FAU - Hung, Ivan Fan-Ngai AU - Hung IF FAU - Fung, James AU - Fung J FAU - Lai, Ching-Lung AU - Lai CL FAU - Yuen, Man-Fung AU - Yuen MF LA - eng PT - Comparative Study PT - Journal Article PL - Australia TA - J Gastroenterol Hepatol JT - Journal of gastroenterology and hepatology JID - 8607909 RN - 0 (DNA, Viral) RN - 0 (HLA-DP alpha-Chains) RN - 0 (HLA-DPA1 antigen) RN - 0 (Hepatitis B e Antigens) RN - 0 (Receptors, Interferon) SB - IM MH - Adult MH - Age Factors MH - Aged MH - DNA, Viral MH - Female MH - Gene Frequency MH - HLA-DP alpha-Chains/*genetics MH - Hepatitis B e Antigens MH - Hepatitis B virus/genetics MH - Hepatitis B, Chronic/*genetics/*virology MH - Humans MH - Male MH - Middle Aged MH - *Polymorphism, Single Nucleotide MH - Receptors, Interferon/*genetics MH - Signal Transduction/genetics MH - Viral Load/*genetics MH - Young Adult MH - Interferon gamma Receptor OTO - NOTNLM OT - HLA-DP OT - IFN-gamma pathway OT - chronic hepatitis B EDAT- 2013/08/29 06:00 MHDA- 2014/11/02 06:00 CRDT- 2013/08/29 06:00 PHST- 2013/08/09 00:00 [accepted] PHST- 2013/08/29 06:00 [entrez] PHST- 2013/08/29 06:00 [pubmed] PHST- 2014/11/02 06:00 [medline] AID - 10.1111/jgh.12378 [doi] PST - ppublish SO - J Gastroenterol Hepatol. 2014 Mar;29(3):533-9. doi: 10.1111/jgh.12378.